Activity of quinupristin/dalfopristin and its components against Haemophilus influenzae

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue SUPPL. A, 1997, Pages 69-73

  Jorgensen, James H ^a   Leticia McElmeel, M ^a  

^a University of Texas Health Science Center at San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFUROXIME; CHLORAMPHENICOL; COTRIMOXAZOLE; DALFOPRISTIN; ERYTHROMYCIN; QUINUPRISTIN; RIFAMPICIN; STREPTOGRAMIN DERIVATIVE; TETRACYCLINE;

ANTIBACTERIAL ACTIVITY; ARTICLE; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

AMPICILLIN; ANTI-BACTERIAL AGENTS; CULTURE MEDIA; ERYTHROMYCIN; HAEMOPHILUS INFLUENZAE; MICROBIAL SENSITIVITY TESTS; PENICILLINS; VIRGINIAMYCIN;

EID: 1842407764     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.suppl_1.69     Document Type: Article

References (12)

1. Bouanchaud, D. H. (1992). In vitro and in vivo synergistic activity and fractional inhibitory concentration (FIG) of the compounds of a semisynthetic streptogramin, RP59500. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 95-9.
2. Aumercier, M., Bouhallab, S., Capmau, M. L. & Le Goffic, F. (1992). RP59500: a proposed mechanism for its bactericidal action. Antimicrobial Agents and Chemotherapy 39, Suppl. A, 9-14.
3. Leclercq, R., Nantas, L., Soussy, C. J. & Duval, J. (1992). Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 67-75.
4. Neu, H. C., Chin, N. X. & Gu, J. W. (1992). The in-vitro activities of new streptogramins, RP59500, RP57669, and RP54476, alone and in combination. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 83-4.
5. Barry, A. L. & Fuchs, P. C. (1995). In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens. Antimicrobial Agents and Chemotherapy 39, 238-40.
6. Dabernat, H. (1993). Evaluation of in vitro activity of prtstinamycin against Haemophilus influenzae. Pathologie Biologie 41, 641-6.
7. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard M7-A3. NCCLS, Villanova, PA.
8. National Committee for Clinical Laboratory Standards. (1985). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard M7-A. NCCLS, Villanova, PA.
9. Jorgensen, J. H., Redding, J. S., Maher, L. A. & Howell, A. W. (1987). Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae. Journal of Clinical Microbiology 25, 2105-13.
10. Archer, G. L., Auger, P., Doern, G. V., Ferraro, M. J., Jorgensen, J. H., Low, D. E. et al. (1993). RP59500, a new streptogramin highly active against recent isolates of North American staphylococci. Diagnostic Microbiology and Infectious Disease 16, 223-6.
11. Collins, L. A., Malanoski, G. J., Eliopoulos, G. M., Wennersten, C. B., Ferraro, M. J. & Moellering, R. C. (1993). In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant Gram-positive organisms. Antimicrobial Agents and Chemotherapy 37, 598-601.
12. National Committee for Clinical Laboratory Standards. (1994). Minimum Inhibitory Concentration (MIC) Interpretive Standards For Haemophilus spp. Approved Standard M7-A3, NCCLS, Villanova, PA.